Press releases
Find all AMBAR press releases below.
Press clipping
Date | Media | Headline |
---|---|---|
20 MAY, 2021 | The New Barcelona Post | Grifols abre en Barcelona su primer centro para frenar el avance del alzhéimer |
19 MAY, 2021 | La Vanguardia | Abre en Barcelona un centro pionero para tratar el alzheimer con recambio de plasma |
19 MAY, 2021 | Europa Press | Grifols y ACE impulsan un Ambar Center en Barcelona para el estudio del Alzheimer |
19 MAY, 2021 | ABC | Grifols y la fundación Ace inauguran el primer Ambar Center para investigar el alzhéimer en Barcelona |
19 MAY, 2021 | La Vanguardia | Grifols empezará a aplicar en Barcelona su tratamiento para el alzhéimer |
19 MAY, 2021 | Diario Médico | Grifols confía a ACE su primer Ambar Center para Alzheimer |
AMBAR results published in Alzheimer's & Dementia
Press clipping
CTAD 2019 (December 6, 2019 | San Diego, CA. USA)
AAIC 2019 (July 16, 2019 | Los Angeles, CA. USA)
AD/PD 2019 (March 29, 2019 | Lisboa, Portugal)
Press clipping
CTAD 2018 (October 27, 2018 | Barcelona, Spain)
Press clipping
CTAD 2015 (November 6, 2015 | Barcelona, Spain)
AMBAR study 2012 launch (July 3, 2012 | Barcelona, Spain)
Press clipping
Date | Media | Headline |
---|---|---|
28 SEP, 2017 | Nature Outlook | Neuroscience: The power of plasma |
28 SEP, 2017 | Nature Outlook | Therapeutic plasma proteins: their incredible potential as a source of health (sponsored) |
Inquiries
Journalist or media professional?
Our media relations team is available at:
media@grifols.com
(+34) 93 571 00 02
Restricted to media inquiries only
Not a journalist?
For general questions and requests, please contact: ambar.inquiries@grifols.com
AMBAR®: Research in Alzheimer's disease
More than 15 years of research in Alzheimer's, a disease that is estimated to affect 35 million people worldwide.
AMBAR® Clinical Program
AMBAR® is an innovative procedure aimed at slowing down the progression of Alzheimer's disease through periodic plasma exchange with albumin.